Filter News
Area of Research
- (-) Clean Energy (29)
- (-) Nuclear Science and Technology (2)
- Advanced Manufacturing (1)
- Biology and Environment (7)
- Computer Science (2)
- Fusion and Fission (1)
- Isotopes (6)
- Materials (25)
- Materials for Computing (3)
- National Security (10)
- Neutron Science (3)
- Quantum information Science (1)
- Supercomputing (10)
News Topics
- (-) Cybersecurity (3)
- (-) Energy Storage (26)
- (-) Isotopes (3)
- 3-D Printing/Advanced Manufacturing (29)
- Advanced Reactors (4)
- Artificial Intelligence (4)
- Big Data (1)
- Bioenergy (14)
- Biology (5)
- Biomedical (4)
- Biotechnology (2)
- Buildings (8)
- Chemical Sciences (10)
- Clean Water (1)
- Climate Change (6)
- Composites (5)
- Computer Science (10)
- Coronavirus (4)
- Critical Materials (4)
- Decarbonization (10)
- Environment (13)
- Exascale Computing (2)
- Fossil Energy (1)
- Frontier (1)
- Fusion (2)
- Grid (9)
- High-Performance Computing (2)
- Machine Learning (4)
- Materials (17)
- Materials Science (12)
- Mercury (1)
- Microscopy (4)
- Molten Salt (1)
- Nanotechnology (5)
- National Security (4)
- Net Zero (1)
- Neutron Science (8)
- Nuclear Energy (10)
- Partnerships (8)
- Physics (2)
- Polymers (5)
- Quantum Science (1)
- Renewable Energy (1)
- Security (3)
- Simulation (1)
- Space Exploration (2)
- Summit (2)
- Sustainable Energy (24)
- Transformational Challenge Reactor (3)
- Transportation (17)
Media Contacts
The Department of Energy’s Oak Ridge National Laboratory is now producing actinium-227 (Ac-227) to meet projected demand for a highly effective cancer drug through a 10-year contract between the U.S. DOE Isotope Program and Bayer.